Idiopathic Granulomatous Mastitis
8
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
GRAnulomatous MAstitis REGistry Study
Steroid Injection in Idiopathic Granulomatous Mastitis
Baricitinib in Idiopathic Granulomatous Mastitis
Comparing Effectiveness of Steroids and Methotrexate in Treatment of Chronic Inflammatory Breast Disease
Risk Factors and the Role of Albumin-to-globulin Ratio in Idiopathic Granulomatous Mastitis
Idiopathic Granulomatous Mastitis Combination Therapy
Idiopathic Granulomatous Mastitis
An Integrative Approach for Idiopathic Granulomatous Mastitis.